Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
One World ProductsOWPC +66.67% Debt-to-Equity is -0.95 as of Sep. 2025. The stock has 4 warning signs investors should review. Among 813 Drug Manufacturers companies, One World Products ranks worse than 123001.11% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for One World Products's Debt-to-Equity or its related term are showing as below:
OWPC'
s Debt-to-Equity Range Over the Past 10 Years
Min: -59.52 Med: -0.36 Max: 14.43
Current: -0.95
During the past 11 years, the highest Debt-to-Equity Ratio of One World Products was 14.43. The lowest was -59.52. And the median was -0.36.
OWPC's Debt-to-Equity is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.27
vs OWPC: -0.95
One World Products (OTCPK:OWPC) Debt-to-Equity Explanation
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
One World Products Debt-to-Equity Related Terms
One World Products Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for One World Products's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OWPC vs CBSTQ, PTPI, KOAN: Debt-to-Equity Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, One World Products's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
One World Products Debt-to-Equity vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, One World Products's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where One World Products's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
One World Products (OWPC) has a Debt-to-Equity of -0.95 as of Sep. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on One World Products and its competitors. According to the industry distribution chart, One World Products ranks #999999 out of 813 companies in the Drug Manufacturers industry.
Is One World Products' Debt-to-Equity too high?
One World Products' current Debt-to-Equity is -0.95. Based on the distribution chart, One World Products ranks #999999 out of 813 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does One World Products' Debt-to-Equity compare to CBSTQ and PTPI?
According to the Drug Manufacturers industry distribution chart, One World Products ranks #999999 out of 813 companies for Debt-to-Equity. This places One World Products in the lower half of its industry. The industry median Debt-to-Equity is 0.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Drug Manufacturers company?
The median Debt-to-Equity among Drug Manufacturers companies is 0.27, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on One World Products and its competitors. For the Drug Manufacturers industry, the median Debt-to-Equity is 0.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. One World Products's current Debt-to-Equity is -0.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is One World Products stock overvalued right now?
One World Products (OWPC) has a current Debt-to-Equity of -0.95. The current Debt-to-Equity is -0.95. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For One World Products (OWPC), the current Debt-to-Equity is -0.95 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
One World Products Inc along with its subsidiaries is engaged in the cultivation, production, and distribution of raw cannabis and hemp plant ingredients for both medical and industrial uses. It focuses on cultivating, processing, and supplying cannabis oil, distillate, and isolate to customer's specifications. The Company operates as a single segment, consisting of its CBD sales operations in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OWPC has been successfully added to your 
